STOCK TITAN
  1. Home
  2. Sec-filings
  3. SXT
  4. [Form 4] SENSIENT TECHNOLOGIES CORP Insider Trading Activity

Sensient (SXT) Director Fee Deferral Recorded on Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Insider transaction summary for Sensient Technologies (SXT): On 09/30/2025 director Deborah McKeithan Gebhardt reported changes in her beneficial ownership. The filing records a disposition of 16,332.571 shares of common stock and the acquisition by deferral of 87.187 units of deferred stock under the directors' deferred compensation plan. Deferred stock converts one-for-one into common shares and those 87.187 shares will be issued when her director service ends. The Form 4 was signed on 10/01/2025 by an attorney-in-fact. All items reflect director fee deferrals, restricted stock, and shares held in a dividend reinvestment plan as described in the explanations.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine director compensation deferral and a reported disposition; no material change to control or capital structure.

The Form 4 reflects a director electing to defer fees into deferred stock and reporting a disposal of 16,332.571 common shares on 09/30/2025. The 87.187 deferred-stock units convert one-for-one to common shares and are payable upon termination of board service. These are compensation-related transactions rather than open-market strategic trades, so they generally do not signal a change in corporate control or immediate dilution. The disclosure appears complete for the reported events.

TL;DR: Compensation deferral documented correctly; governance implications are routine and non-material.

The filing shows the director used the Issuer's Directors' Deferred Compensation Plan to defer fees into deferred stock and reports restricted-stock and dividend reinvestment holdings. The disclosure includes the mechanics (one-for-one conversion and issuance upon termination). From a governance perspective, these are standard director compensation arrangements with appropriate Form 4 reporting and no immediate governance concerns disclosed.

Insider McKeithan Gebhardt Deborah
Role Director
Type Security Shares Price Value
Grant/Award Deferred Stock 87.187 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Deferred Stock — 5,575.607 shares (Direct); Common Stock — 16,332.571 shares (Direct)
Footnotes (1)
  1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Deferred stock converts to common stock on a one-for-one basis. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
McKeithan Gebhardt Deborah
(Last) (First) (Middle)
777 EAST WISCONSIN AVENUE
(Street)
MILWAUKEE WI 53202
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 16,332.571(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock (2) 09/30/2025 A(3) 87.187 (4) (4) Common Stock 87.187 $0 5,575.607 D
Explanation of Responses:
1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
2. Deferred stock converts to common stock on a one-for-one basis.
3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
/s/ John J. Manning, Attorney-in-Fact for Ms. McKeithan-Gebhardt 10/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Deborah McKeithan Gebhardt report on Form 4 for SXT?

She reported a disposition of 16,332.571 common shares and the acquisition by deferral of 87.187 deferred stock units on 09/30/2025.

When do the deferred stock units convert to common shares for SXT?

Deferred stock converts one-for-one into common stock and the filing states those shares will be issued upon termination of the reporting person's director service.

What was the reason for acquiring the deferred stock units in the SXT Form 4?

The filing states the acquisition resulted from deferral of director fees under the Issuer's Directors' Deferred Compensation Plan.

Who signed the Form 4 for Deborah McKeithan Gebhardt?

The Form 4 was signed on behalf of Ms. McKeithan-Gebhardt by John J. Manning, Attorney-in-Fact on 10/01/2025.

Does the Form 4 indicate any change in control of SXT?

No. The filing documents compensation deferral and routine holdings; it does not indicate a change in control or material corporate action.